Added to YB: 2025-11-19
Pitch date: 2025-11-17
SNSE [neutral]
Sensei Biotherapeutics, Inc.
+1.79%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
Market Cap
$10.1M
Pitch Price
$8.40
Price Target
21.70 (+154%)
Dividend
N/A
EV/EBITDA
0.62
P/E
-0.42
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Liquidations Watchlist - Potential Liquidations: Sensei Biotherapeutics Inc
SNSE (liquidation): Clinical-stage biotech exploring strategic alternatives incl asset sale, licensing, merger, or wind-down after workforce cuts. Burning ~$12M/yr G&A, $28.5M cash remaining. NAV $21.7 book value but uncertain asset/IP value in distressed situation.
Read full article (1 min)